last
decad
africa
remain
contin
afflict
seriou
extent
hivaid
pandem
although
number
infect
elsewher
instanc
asia
also
rise
mani
children
die
rel
prevent
caus
especi
place
high
incid
hiv
infectionsaid
search
plant
extract
antihiv
activ
continu
polysaccharid
compound
propos
use
treatment
lectin
extens
studi
possess
varieti
potenti
exploit
activ
purpos
articl
review
lectin
antihiv
activ
lectin
carbohydratebind
protein
nonimmunoglobulin
natur
capabl
recognit
revers
bind
complic
glycoconjug
moieti
without
alter
coval
structur
recogn
glycosyl
ligand
natur
lectin
distribut
across
wide
varieti
organ
like
alga
fungi
sea
coral
higher
plant
prokaryot
invertebr
vertebr
involv
mani
biolog
process
like
recognit
bind
carbohydr
hostpathogen
interact
cell
target
cellcel
commun
induct
apoptosi
cancer
metastasi
differenti
antivir
antifung
antibacteri
activ
lectin
report
intent
articl
review
lectin
antihiv
activ
human
immunodefici
viru
hiv
type
envelop
viru
caus
acquir
immunodefici
syndrom
aid
human
condit
manifest
progress
failur
immun
system
infect
viral
cell
thelper
cell
macrophag
dendrit
cell
infect
lead
low
level
number
mechan
also
apoptosi
uninfect
cell
direct
viral
kill
infect
cell
kill
infect
cell
cytotox
lymphocyt
occur
envelop
protein
complex
determin
viral
tropism
facilit
membran
fusion
process
allow
invas
viral
genom
precursor
env
gene
code
later
process
host
cell
proteas
form
cleavag
product
envelop
protein
complex
extens
glycosyl
proteolyt
cleav
new
viru
particl
come
host
cell
lie
opposit
side
viru
membran
sit
outsid
viru
particl
form
viru
spike
sit
insid
membran
anchor
membran
bind
receptor
target
cell
receptor
present
tlymphocyt
macrophag
associ
spontan
mutat
env
gene
presenc
enough
mutant
strain
infect
human
cell
strain
seven
mutat
sequenc
code
also
propos
mutat
induc
conform
chang
allow
viru
directli
interact
prior
bind
host
cell
remain
effect
hidden
antibodi
buri
protein
shield
sugar
make
neutral
antibodi
difficult
expos
close
proxim
host
cell
space
viral
host
cell
membran
small
enough
hinder
bind
antibodi
one
reason
vaccin
avail
hiv
noncoval
bound
buri
within
viral
envelop
bind
chang
conform
becom
expos
assist
fusion
host
cell
lectin
exhibit
signific
activ
human
immunodefici
viru
hiv
virus
envelop
make
particularli
attract
target
develop
novel
antivir
drug
cyanovirinn
griffithsin
exampl
lectin
inhibit
hiv
virus
viral
encod
glycoprotein
cover
surfac
retrovirus
hiv
mani
virus
envelop
present
envelop
hiv
heavili
glycosyl
glycan
estim
contribut
almost
molecular
weight
agent
strongli
specif
interact
glycan
may
disturb
interact
cell
host
protein
viral
envelop
viral
surfac
sugarbind
protein
crosslink
glycan
prevent
interact
coreceptor
antivir
lectin
prevent
penetr
host
cell
virus
prevent
infect
bind
sugar
adorn
surfac
envelop
hiv
major
current
antivir
therapeut
act
inhibit
viral
life
cycl
antivir
lectin
suitabl
topic
applic
exhibit
lower
toxic
other
use
antivir
therapi
antivir
protein
often
resist
low
ph
high
temperatur
also
odorless
properti
favor
potenti
drug
exampl
lectin
exhibit
antivir
activ
bind
highmannos
carbohydr
jacalin
concanavalin
urtica
diocia
agglutinin
myrianthu
holstii
lectin
p
tetragonolobu
lectin
narcissu
pseudonarcissu
lectin
lectin
also
deriv
marin
organ
natur
antivir
product
exhibit
highest
activ
among
lectin
cyanovirinn
scytovirin
microcysti
virdi
lectin
griffithsin
jacalin
major
protein
jackfruit
artocarpu
heterophyllu
seed
artocarpu
heterophyllu
moracea
famili
evergreen
tree
grown
variou
tropic
countri
south
southeast
asia
seed
larg
oblong
brown
tegmen
slim
membran
testa
chatterje
et
al
roquebarreira
et
al
kondoh
et
al
among
first
identifi
jacalin
around
jacalin
properti
bind
human
iga
specif
subclass
recent
year
variou
studi
carri
jacalin
reveal
import
lectin
divers
applic
rang
isol
human
hiv
research
jacalin
report
molecular
mass
kda
seed
fruit
contain
minor
mannosebind
lectin
twochain
lectin
consist
amino
acid
residu
noncoval
bound
amino
acid
residu
glycosyl
molecular
mass
kda
sugar
interact
lectinicsit
jacalin
suppress
bind
jacalin
find
give
insight
mechan
jacalin
inhibit
infect
cell
concanavalin
carbohydratebind
protein
isol
canavalia
ensiformi
jack
bean
member
legum
lectin
famili
use
human
nutrit
anim
fodder
bean
plant
mildli
toxic
copiou
consumpt
avoid
concanavalin
first
lectin
avail
commerci
basi
wide
use
biolog
biochemistri
character
glycoprotein
sugarcontain
entiti
surfac
variou
cell
plant
contain
larg
quantiti
enzym
ureas
reason
plant
use
fodder
mixtur
contain
urea
liber
harm
ammonia
urea
plant
investig
potenti
sourc
ureas
enzym
concanavalin
homotetram
molecular
mass
kda
amino
acid
residu
bind
specif
certain
structur
found
sever
glycoprotein
sugar
glycolipid
especi
intern
nonreduc
termin
group
con
bind
envelop
glycoprotein
howev
resist
strain
report
detail
mechan
lectinmedi
neutral
complet
elucid
minimum
two
mechan
direct
one
indirect
mechan
account
efficaci
remov
glycan
render
hiv
resist
direct
mechan
mutat
nglycosyl
site
harbor
key
target
glycan
lectinmedi
neutral
remov
mutat
bind
lectin
glycan
either
prevent
hiv
bind
receptor
cell
affect
alter
follow
bind
indirect
mechan
suggest
remov
one
nglycosyl
site
render
nglycan
elsewher
expos
carbohydras
golgi
bodi
endoplasm
reticulum
local
chang
util
glycosyl
site
affect
glycosyl
setup
protein
fold
thu
lectinbind
highmannos
glycan
wild
type
probabl
highli
process
lectinselect
strain
lead
loss
affin
gnarel
lectin
nearli
relat
carbohydratebind
activ
exhibit
signific
antihiv
antihsv
antitumor
action
gnarel
lectin
exhibit
mannosebind
activ
polygonatum
cyrtonema
lectin
ophiopogon
japonica
lectin
also
display
carbohydr
affin
sialic
acid
agent
interact
viralenvelop
glycan
may
compromis
effici
entri
viru
suscept
target
cell
interfer
glycosyl
enzym
cell
rather
act
directli
bind
intact
glycan
envelop
kind
carbohydratebind
agent
forc
viru
delet
part
glycan
shield
escap
drug
pressur
result
initi
immun
respons
uncov
immunogen
envelop
epitop
mechan
antivir
action
carbohydratebind
agent
firstli
direct
antivir
activ
bind
glycan
viral
envelop
block
entri
viru
secondli
indirect
antivir
action
result
progress
creation
delet
glycan
shield
envelop
immun
system
trigger
act
previous
hidden
immunogen
epitop
viral
envelop
agglutinin
hippeastrum
hybrid
galanthu
nivali
inhibit
cellcel
fusion
cell
induc
express
viral
envelop
protein
env
highli
cell
mannosespecif
plant
lectin
hippeastrum
hybrid
agglutinin
galanthu
nivali
agglutinin
narcissu
pseudonarcissu
agglutinin
cymbidium
agglutinin
cyanovirinn
nacetylglucosamin
specif
urtica
dioica
agglutinin
effici
abrog
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
direct
captur
subsequ
transmiss
lymphocyt
mannosespecif
plant
lectin
galanthu
hippeastrum
narcissu
epipacti
helleborin
listera
ovata
nacetylglucosaminespecif
urtica
dioica
lectin
would
primarili
target
viruscel
fusion
process
banana
lectin
bind
glycosyl
viral
envelop
inhibit
cellular
entri
thu
suppress
infect
antihiv
activ
compar
snowdrop
lectin
griffithsin
antihiv
drug
maraviroc
myrianthu
holstii
tree
larg
branch
grow
meter
height
urticacea
famili
often
stilt
root
cm
high
short
bole
plant
harvest
wild
local
sourc
food
wood
tree
grown
middl
africa
rainforest
montan
forest
edg
regrowth
along
river
myrianthu
holstii
lectin
obtain
root
chromatographi
molecular
mass
kda
lectin
consist
two
major
constitu
molecular
mass
da
respect
myrianthu
holstii
lectin
protect
cemss
cell
cytopath
effect
hiv
valu
nm
one
similar
urtica
diocia
agglutinin
nm
inhibit
syncytium
format
valu
indic
lectin
revers
inhibit
hiv
infect
narcissu
pseudonarcissu
also
known
wild
daffodil
lent
lili
belong
amaryllidacea
famili
plant
produc
seed
nativ
western
europ
grow
wood
grassland
rocki
ground
contain
dimer
protein
molecular
mass
kda
compos
two
subunit
specif
toward
mannos
use
character
earli
stage
apoptosi
mitogen
activ
toward
human
lymphocyt
lectin
agglutin
rabbit
erythrocyt
nonreact
human
erythrocyt
mannosebind
agglutinin
narcissu
speci
also
manifest
infect
inhibitori
activ
like
narcissu
pseudonarcissu
agglutinin
infect
inhibitori
activ
correl
hemagglutin
activ
compar
analys
reveal
dimerbas
superstructur
may
import
antihiv
properti
polygonatum
cyrtonema
lectin
novel
antihiv
mannosebind
lectin
galanthu
nivali
agglutininrel
lectin
famili
urtica
diocia
herbac
perenni
flower
plant
often
call
sting
nettl
common
nettl
grow
europ
north
america
africa
asia
grow
meter
height
long
histori
use
sourc
fiber
food
medicin
urtica
diocia
agglutinin
special
plant
lectin
differ
plant
lectin
cytopath
effect
hiv
rate
nm
small
molecular
mass
kda
cell
mitogen
distinguish
classic
cell
lectin
mitogen
abl
discrimin
particular
popul
cell
induc
origin
pattern
cell
cytokin
product
well
activ
plant
lectin
mitogen
success
extens
use
analysi
event
occur
lymphocyt
activ
prolifer
lectin
suppress
entri
host
cell
halfmaxim
effect
concentr
nm
surfac
plasmon
reson
analysi
disclos
high
associ
constant
lectin
lectin
bind
viral
envelop
hemagglutinin
variou
strain
includ
clinic
isol
pandem
viru
indic
potenti
use
antivir
therapi
griffithsin
protein
amino
acid
isol
red
alga
griffithsia
protein
highli
potent
hiv
entri
inhibitor
block
bind
receptor
express
cell
bind
gp
like
happen
glycosylationdepend
manner
inhibit
bind
monoclon
antibodi
mab
recogn
carbohydratedepend
motif
mab
bind
epitop
griffithsin
also
moder
interf
bind
bind
griffithsin
solubl
inhibit
fucos
xylos
galactos
nacetylgalactosamin
sialic
acid
contain
glycoprotein
inhibit
mannos
glucos
nacetylglucosamin
griffithsin
bind
termin
mannos
residu
surfac
nlink
glycan
ebola
viru
hepat
c
viru
sever
acut
respiratori
syndrom
coronaviru
mean
type
lectin
bind
sever
viral
glycoprotein
monosaccharidedepend
manner
griffithsin
interact
lead
exposur
site
bind
glycan
posit
unlik
cyanovirin
galanthu
nivali
agglutinin
interact
griffithsin
reli
specif
trimer
sugar
tower
includ
support
find
griffithsin
env
bind
experi
griffithsin
mitogen
activ
toward
human
tcell
elicit
secret
proinflammatori
cytokin
treat
human
cell
line
subutan
inject
griffithsin
induc
toxic
splenomegali
hepatomegali
serum
sampl
griffithsintr
anim
display
activ
pseudovirus
cellbas
neutral
assay
griffithsin
suppress
hiv
bind
dcsign
dcsignmedi
transfer
tlymphocyt
drive
away
complex
function
intact
carbohydr
bind
site
essenti
optim
action
dimer
form
paramount
hiv
inhibitori
action
griffithsin
synerg
antivir
drug
enfuvirtid
maraviroc
tenofovir
clade
b
clade
c
isol
primari
peripher
blood
mononuclear
cell
cell
dissimilar
glycosyl
pattern
viral
envelop
clade
b
clade
c
affect
synerg
howev
discrep
exist
bind
activ
hiv
inhibitori
activ
griffithsin
variant
suggest
presenc
antihiv
mechan
unrel
simpl
bind
griffithsin
three
nearlyequival
mannos
bind
site
essenti
antihiv
activ
griffithsin
mutant
mutat
one
three
site
demonstr
fold
decrement
bind
immobil
fold
declin
hiv
inhibit
abil
singleround
hiv
infect
assay
hiv
cytopath
assay
cocultiv
assay
exhibit
superior
hiv
inhibitori
activ
despit
reduc
bind
activ
compar
strain
furnish
evid
absenc
direct
correl
bind
hiv
hiv
inhibit
henc
bind
necessarili
ensu
antivir
effect
antihiv
mechan
griffithsin
action
involv
bind
steric
hinder
activ
importantli
alter
structur
oligomer
state
consequ
bind
mannos
residu
crosslink
glycan
render
hiv
uninfect
griffithsin
interact
lead
exposur
site
bind
glycan
posit
unlik
cyanovirin
galanthu
nivali
agglutinin
interact
griffithsin
reli
specif
trimer
sugar
tower
includ
support
find
griffithsin
env
bind
experi
howev
discrep
exist
bind
activ
hiv
inhibitori
activ
griffithsin
variant
suggest
presenc
antihiv
mechan
unrel
simpl
bind
griffithsin
synerg
carbohydratebind
agent
inhibitori
action
even
strain
demonstr
resist
carbohydratebind
agent
carbohydratebind
agent
test
differ
bind
pattern
envelop
henc
steric
hindranc
observ
open
possibl
employ
combin
carbohydr
bind
agent
topic
microbicid
agent
counter
hiv
transmiss
mannosebind
lectin
green
alga
oscillatoria
agardhii
oaa
select
cluster
homologu
oscillatoria
agardhii
agglutinin
homologu
oaah
design
hybrid
oaah
opa
inhibit
hiv
replic
syncytium
format
uninfect
cell
dcsignmedi
captur
transmiss
target
cell
infect
varieti
clinic
isol
surfac
plasmon
reson
analysi
flow
cytometri
reveal
competit
inhibitor
bind
manspecif
monoclon
antibodi
mvnre
iiib
grftre
strain
inhibit
well
wildtyp
strain
oaa
opa
synerg
hippeastrum
hybrid
agglutinin
griffithsin
combin
grft
cba
show
synergist
activ
even
certain
cbaresist
strain
cba
test
appear
distinct
bind
pattern
envelop
therefor
necessarili
compet
glycan
bind
site
result
might
steric
hindranc
two
differ
cba
competit
glycan
bind
except
hhagna
combin
data
encourag
use
pair
cba
combin
topic
microbicid
applic
eg
cream
gel
intravagin
ring
prevent
hiv
transmiss
combin
nmr
crystallograph
result
provid
structur
insight
mechan
oaa
specif
recogn
branch
core
distinctli
differ
recognit
arm
nonreduc
end
highmannos
carbohydr
antivir
lectin
cyanovirinn
bacteri
protein
produc
cyanobacterium
nostoc
ellipsosporum
show
virucid
activ
sever
virus
entri
inhibitor
hiv
discov
screen
program
search
natur
occur
virucid
agent
may
develop
antihiv
microbicid
protein
consist
singl
amino
acid
chain
exhibit
signific
intern
sequenc
duplic
reveal
conserv
amino
acid
chang
well
direct
homolog
amino
acid
residu
molecular
mass
approxim
kda
also
consist
four
cystein
form
two
intrachain
disulfid
bond
intact
disulfid
bond
appear
requir
antihiv
activ
cleavag
bond
happen
due
treatment
hiv
inhibitori
effect
abolish
store
solut
phase
reduc
cyanovirinn
could
reform
requir
disulfid
bond
accompani
recoveri
antihiv
activ
cyanovirinn
inhibit
vitro
cytopath
laboratori
strain
sever
clinic
isol
hiv
type
simian
immunodefici
viru
also
effect
prevent
celltocel
fusion
transmiss
hiv
infect
cell
uninfect
cell
hiv
virion
undergon
pretreat
cyanovirinn
neutral
viru
infect
nontox
host
cell
uniqu
virucid
effect
aris
associ
viral
envelop
glycoprotein
cyanovirinn
interfer
critic
interact
viral
cell
surfac
receptor
requir
success
viru
fusion
entri
cell
linkercyanovirinn
cyanovirinn
deriv
flexibl
hydrophil
linker
nterminu
k
pegaldlcvn
ntermin
ntermin
linker
cyanovirinn
pegyl
creat
k
pegaldehyd
linker
cyanovirinn
character
specif
affin
cyanovirinn
high
mannos
nglycan
linker
cyanovirinn
display
activ
reduscd
cytotox
cat
keratinocyt
lymphocyt
k
pegaldlcvn
inactiv
markedli
decreas
cytotox
pronounc
celltocel
fusion
inhibitori
activ
vitro
linkerextend
cyanovirinn
monopegyl
deriv
thu
promis
candid
develop
agent
humic
acid
potenti
antihiv
activ
azt
griffithsin
cyanovirin
cvn
specif
recogn
nanomolar
affin
man
glcnac
isom
man
glcnac
scytovirin
antivir
protein
isol
cyanobacterium
scytonema
varium
protein
consist
singl
acid
chain
molecular
mass
kda
signific
intern
sequenc
duplic
cystein
form
five
intrachain
disulfid
bond
svn
contain
two
homolog
domain
one
compris
amino
acid
second
amino
acid
display
antihiv
activ
analog
demonstr
weaker
activ
fulllength
svn
delet
mutant
domain
svn
svn
svn
reveal
import
ntermin
residu
antihiv
activ
delet
eight
ctermin
svn
amino
acid
markedli
reduc
antihiv
activ
two
carbohydratebind
site
differ
affin
cvn
specif
recogn
nanomolar
affin
man
glcnac
isom
man
glcnac
microcysti
viridi
unicellular
freshwat
bloomform
cyanobacterium
show
transient
hemagglutin
activ
laboratori
cultur
stationari
phase
nonaer
condit
lectin
compos
singl
polypeptid
amino
acid
residu
two
tandemli
repeat
homolog
domain
amino
residu
microcysti
viridi
lectin
bind
oligomannosid
submicromolar
affin
two
novel
carbohydr
recognit
domain
compos
four
noncontigu
region
residu
make
numer
intermolecular
contact
carbohydr
ligand
lectin
inhibit
hiv
type
envelopemedi
cell
fusion
cyanobacteri
lectin
microvirin
potenti
exploit
sinc
potent
inhibit
minim
toxic
synchron
infect
assay
reveal
differ
kinet
entri
inhibit
microvirin
cyanovirin
synerg
demonstr
combin
inhibitor
spite
common
specif
man
termin
indic
recognit
distinctli
differ
glycan
andor
glycan
conform
entri
assay
util
amphotrop
virus
disclos
inact
microvirin
contrast
potent
inhibitori
activ
cyanovirin
view
similar
carbohydratebind
site
common
microvirin
cyanovirin
appear
cluster
glycan
epitop
multivalentprotein
interact
applic
cyanovirin
microvirin
need
inhibit
certain
virus
actinohivin
actinomycet
lectin
compos
amino
acid
residu
contain
three
segment
display
high
specif
affin
due
multival
interact
three
sugarbind
pocket
three
highmannos
type
glycan
hmtg
via
cluster
effect
lectin
exhibit
potent
vitro
antihiv
activ
actinohivin
suppress
entri
suscept
cell
specif
potent
antihiv
activ
produc
cooper
bind
three
segment
actinohivin
three
high
mannosetyp
glycan
hmtg
antihiv
activ
actinohivin
enhanc
dimer
due
rise
number
hmtgbind
pocket
lectin
inhibit
cytopath
effect
brought
product
viral
antigen
effect
earli
stage
viral
replic
disclos
timeofaddit
analysi
activ
indic
lectin
inhibit
celltocel
fusion
hiv
infect
uninfect
cell
suppress
entri
host
cell
shown
employ
fluorescencebas
realtim
quantifi
pcr
lectin
inhibit
product
viral
antigen
cytopath
effect
induc
hiv
valu
respect
dendrit
cell
dc
play
vital
role
transmiss
dc
captur
assault
via
interact
ctype
lectin
dcsign
oligosaccharid
transloc
lymphoid
tissu
transmiss
cell
occur
reason
target
inhibit
interact
dc
transmiss
nematod
laxu
oneistu
ctype
lectin
mermaid
structur
homologu
dcsign
devoid
cytotox
share
glycan
specif
dcsign
interact
high
mannos
structur
prevent
bind
dcsign
dc
mermaid
inhibit
dcsignmedi
transmiss
dc
cell
thu
lectin
potenti
develop
agent
pradimicin
benanomicin
nonpeptid
lectin
mimic
recogn
dmannopyranosid
presenc
calcium
ion
exert
antifung
antihiv
activ
bind
mannopyranosidecontain
glycan
pathogen
pradimicin
origin
member
pradimicin
bind
termin
dmannopyranosid
residu
nonreduc
end
glycan
well
intern
mannopyranosid
residu
mannos
bind
lectin
trigger
complement
pathway
culmin
pathogen
opson
phagocytosi
mannos
bind
lectin
defici
associ
hiv
transmiss
progress
aid
express
lectin
detect
astrocyt
microglia
neuron
oligodendrocyt
frontal
cortex
hiv
enceph
monomer
trimer
mannos
bind
lectin
express
express
elev
neuron
axon
differenti
mbl
express
observ
healthi
hivneg
subject
normal
transgen
mice
find
indic
mannos
bind
lectin
could
caus
neuroinflamm
neuron
injuri
activ
complement
pathway
brain
earli
stage
infect
lead
damag
impair
central
nervou
system
mannos
bind
lectin
bind
nlink
mannos
residu
neurotoxin
instrument
intravesicular
packag
neuron
subcellular
organel
subcellular
traffick
endoplasm
reticulum
golgi
vesiclesth
vesicular
complex
transloc
along
microtubul
network
function
carbohydr
recognit
domain
necessari
action
mannos
bind
lectin
summari
use
lectin
extract
variou
sourc
great
promis
potenti
use
futur
hiv
therapi
latest
research
found
potent
result
toward
antihiv
effect
variou
lectin
shown
review
still
vaccin
hiv
nlink
glycan
protect
region
oligomer
potenti
neutral
antibodi
invent
immunolog
escap
mechan
viru
addit
research
fund
order
understand
mechan
also
lectin
research
promot
fund
aid
transit
clinic
applic
mannos
bind
lectin
actinohivin
ah
cyanovirinn
cvn
griffithsin
grft
microcysti
viridi
lectin
mvl
oscillatoria
agardhii
agglutinin
oaa
scytovirin
svn
cyanobacteria
alga
display
high
antihiv
potenc
nanomolarpicomolar
valu
differ
tertiari
quaternari
structur
contain
intern
repeat
within
primari
structur
number
sequenc
repeat
often
correspond
number
domain
bind
site
lectin
pronounc
amino
acid
sequenc
homolog
also
structur
resembl
domain
lectin
distinct
characterist
multimer
andor
manifest
domain
swap
wherea
other
monomer
monomer
cvn
oaa
svn
two
sugar
bind
site
ah
engin
monomer
grft
possess
three
site
domainswap
cvn
mvl
display
four
site
domainswap
grft
six
sugar
bind
site
lectin
recogn
differ
epitop
high
mannos
number
bind
site
protein
andor
number
epitop
recogn
correl
antivir
activ
target
mannos
hiv
inhibit
conform
chang
activ
state
straightforward
deliveri
mode
introduct
rectum
vagina
multifunct
contracept
gel
ring
situ
express
modifi
commens
bacteria
inhabit
gut
vagina
engin
vagin
lactobacillu
strain
propos
mucos
deliveri
human
immunodefici
viru
inhibitor
cyanovirinn
prevent
sexual
transmiss
viru
grft
could
obtain
multigram
quantiti
extract
nicotiana
benthamiana
plant
transduct
tobacco
mosaic
viru
vector
express
lectin
employ
lactobacillu
jensenii
express
antihiv
lectin
curtail
cost
develop
userfriendli
microbicid
antihiv
activ
variou
lectin
summar
tabl
tabl
